Gri Bio Etf Odds of Future Etf Price Finishing Over 19.86
| GRI Etf | USD 0.76 0.03 4.11% |
GRI |
GRI Bio Target Price Odds to finish over 19.86
The tendency of GRI Etf price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 19.86 or more in 90 days |
| 0.76 | 90 days | 19.86 | close to zero percent |
Based on a normal probability distribution, the odds of GRI Bio to move over $ 19.86 or more in 90 days from now is close to zero percent (This GRI Bio probability density function shows the probability of GRI Etf to fall within a particular range of prices over 90 days) . Probability of GRI Bio price to stay between its current price of $ 0.76 and $ 19.86 at the end of the 90-day period is about 26.23 .
Considering the 90-day investment horizon GRI Bio has a beta of -1.39. This usually indicates as returns on its benchmark rise, returns on holding GRI Bio are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, GRI Bio is expected to outperform its benchmark. Moreover GRI Bio has an alpha of 1.7491, implying that it can generate a 1.75 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). GRI Bio Price Density |
| Price |
Predictive Modules for GRI Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as GRI Bio. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.GRI Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. GRI Bio is not an exception. The market had few large corrections towards the GRI Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold GRI Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of GRI Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.75 | |
β | Beta against Dow Jones | -1.39 | |
σ | Overall volatility | 0.22 | |
Ir | Information ratio | 0.08 |
GRI Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of GRI Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for GRI Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| GRI Bio is way too risky over 90 days horizon | |
| GRI Bio has some characteristics of a very speculative penny stock | |
| GRI Bio appears to be risky and price may revert if volatility continues | |
| The company reported the last year's revenue of 21.77 M. Reported Net Loss for the year was (13.04 M) with profit before taxes, overhead, and interest of 0. | |
| GRI Bio has about 183.82 M in cash with (9.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.3. | |
| Latest headline from globenewswire.com: GRI Bio Showcases GRI-0621s Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis | |
| The fund retains 99.63% of its assets under management (AUM) in equities |
GRI Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of GRI Etf often depends not only on the future outlook of the current and potential GRI Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. GRI Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 461.6 K | |
| Cash And Short Term Investments | 1.8 M |
GRI Bio Technical Analysis
GRI Bio's future price can be derived by breaking down and analyzing its technical indicators over time. GRI Etf technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of GRI Bio. In general, you should focus on analyzing GRI Etf price patterns and their correlations with different microeconomic environments and drivers.
GRI Bio Predictive Forecast Models
GRI Bio's time-series forecasting models is one of many GRI Bio's etf analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary GRI Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the etf market movement and maximize returns from investment trading.
Things to note about GRI Bio
Checking the ongoing alerts about GRI Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for GRI Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| GRI Bio is way too risky over 90 days horizon | |
| GRI Bio has some characteristics of a very speculative penny stock | |
| GRI Bio appears to be risky and price may revert if volatility continues | |
| The company reported the last year's revenue of 21.77 M. Reported Net Loss for the year was (13.04 M) with profit before taxes, overhead, and interest of 0. | |
| GRI Bio has about 183.82 M in cash with (9.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.3. | |
| Latest headline from globenewswire.com: GRI Bio Showcases GRI-0621s Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis | |
| The fund retains 99.63% of its assets under management (AUM) in equities |
Other Information on Investing in GRI Etf
GRI Bio financial ratios help investors to determine whether GRI Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GRI with respect to the benefits of owning GRI Bio security.